Defining Immune Reconstitution Inflammatory Syndrome: Evaluation of Expert Opinion versus 2 Case Definitions in a South African Cohort
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There is no validated case definition for human immunodeficiency virus-associated immune reconstitution inflammatory syndrome (IRIS). We measured the level of agreement of 2 published case definitions (hereafter referred to as CD1 and CD2) with expert opinion in a prospective cohort of patients who were starting antiretroviral therapy in South Africa. METHODS: A total of 498 adult patients were monitored for the first 6 months of antiretroviral therapy. All new or worsening clinical events were reviewed by 2 investigators and classified on the basis of expert opinion, CD1, and CD2. Events were categorized according to whether they were paradoxical or unmasking in presentation. We measured positive, negative, and chance-corrected agreement (kappa) with expert opinion for CD1 and CD2, and reviewed areas of disagreement. RESULTS: A total of 620 clinical events were recorded, of which, on the basis of expert opinion, 144 (23.2%) were defined as probable IRIS and 112 (18.1%) were defined as possible IRIS. Of the 144 probable IRIS events, 93 (64.6%) were unmasking in presentation, 99 (68.8%) were associated with dermatological or orogenital disease, and 45 (31.3%) were associated with tuberculosis or major opportunistic infections. Of the 620 clinical events recorded, 41 (6.6%) were classified as IRIS on the basis of CD1, and 156 (25.2%) were classified as IRIS on the basis of CD2. Positive agreement between CD1 and expert opinion was low for both unmasking (17.2%; kappa = 0.24) and paradoxical events (37.3%; kappa = 0.43), mainly because 1 major criterion requires IRIS to be atypical and either an opportunistic infection or a tumor, although negative agreement was >98%. In contrast, CD2 had good positive agreement (>75% for most event types), with a kappa value of 0.75 for paradoxical and 0.62 for unmasking. CONCLUSIONS: CD2 agreed well with expert opinion, with additional clinical events, such as arthropathy and inflammatory dermatoses, being classified as IRIS and added to CD2. We propose revised case definitions for both paradoxical and unmasking IRIS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IRIS usually develops after at least several weeks of ART, 90% of cases occur within 3 months after starting ART, and rates are higher when ART is started at lower CD4 cell counts [55, 56].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [55]
In the citing paper
“Definitions of paradoxical IRIS in HIV infection vary but typically require some evidence of response to ART (eg, decreased viral load or increased CD4 cell count) and evidence of a worsening of the complicating infection [55].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [55]
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Meintjes, G., Lawn, S. D., Scano, F., Maartens, G., French, M. A., Worodria, W., Elliott, J. H., Murdoch, D., Wilkinson, R. J., Seyler, C., et al. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70184-1 · Cited by 745
SHELBURNE, S. A., HAMILL, R. J., RODRIGUEZ-BARRADAS, M. C., GREENBERG, S. B., ATMAR, R. L., MUSHER, D. M., GATHE, J. C., VISNEGARWALA, F., & TRAUTNER, B. W. (2002) · Medicine · doi:10.1097/00005792-200205000-00005 · Cited by 654
Immune restoration disease after antiretroviral therapy
French, M. A., Price, P., & Stone, S. F. (2004) · AIDS · doi:10.1097/01.aids.0000131375.21070.06 · Cited by 651
Shelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 632
French, M. A., Lenzo, N., John, M., Mallal, S. A., McKinnon, E. J., James, I. R., Price, P., Flexman, J. P., & Tay‐Kearney, M. (2000) · HIV Medicine · doi:10.1046/j.1468-1293.2000.00012.x · Cited by 413
DeSimone, J. A., Pomerantz, R. J., & Babinchak, T. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00013 · Cited by 383
Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection
Breen, R. A. M. (2004) · Thorax · doi:10.1136/thx.2003.019224 · Cited by 367
Ratnam, I., Chiu, C., Kandala, N. B., & Easterbrook, P. J. (2006) · Clinical Infectious Diseases · doi:10.1086/499356 · Cited by 355
Self-citationLawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2007) · AIDS · doi:10.1097/qad.0b013e328011efac · Cited by 343 · cited 1×
“infection [12–22].”
Lortholary, O., Fontanet, A., Mémain, N., Martin, A., Sitbon, K., & Dromer, F. (2005) · AIDS · doi:10.1097/01.aids.0000174450.70874.30 · Cited by 324
Immune Reconstitution Inflammatory Syndrome: A Reappraisal
French, M. A. (2009) · Clinical Infectious Diseases · doi:10.1086/595006 · Cited by 323
Kambugu, A., Meya, D. B., Rhein, J., O’Brien, M., Janoff, E. N., Ronald, A. R., Kamya, M. R., Mayanja‐Kizza, H., Sande, M. A., Bohjanen, P. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587667 · Cited by 300
Murdoch, D. M., Venter, W. D., Feldman, C., & Van Rie, A. (2008) · AIDS · doi:10.1097/qad.0b013e3282f4a607 · Cited by 280
Breton, G., Duval, X., Estellat, C., Poaletti, X., Bonnet, D., Mvondo Mvondo, D., Longuet, P., Leport, C., & Vildé, J. (2004) · Clinical Infectious Diseases · doi:10.1086/425742 · Cited by 265
Robertson, J., Meier, M., Wall, J., Ying, J., & Fichtenbaum, C. J. (2006) · Clinical Infectious Diseases · doi:10.1086/503903 · Cited by 203
Calabrese, L. H., Kirchner, E., & Shrestha, R. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.03.007 · Cited by 167
Manosuthi, W., Kiertiburanakul, S., Phoorisri, T., & Sungkanuparph, S. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.002 · Cited by 157
Immune reconstitution inflammatory syndrome in HIV
Lipman, M. C. I., & Breen, R. A. M. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000200543.80712.01 · Cited by 156
Jevtović, D., Salemović, D., Ranin, J. T., Pešić, I., Žerjav, S., & Djurković–Djaković, O. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00277.x · Cited by 148
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis.
Burman, W. J., Weis, S. E., Vernon, A. A., Khan, A. Q., Benator, D., Jones, B., Silva, C. R. D. E., King, B., Lahart, C., Mangura, B. T., et al. (2007) · PubMed · Cited by 145
Kumarasamy, N., Chaguturu, S. K., Mayer, K. H., Solomon, S., Yepthomi, H. T., Balakrishnan, P., & Flanigan, T. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200412150-00007 · Cited by 144
Lawn, S. D., Bekker, L.-G., Myer, L., Orrell, C., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000191232.16111.f9 · Cited by 129
French, M. A. (2007) · Current HIV/AIDS Reports · doi:10.1007/s11904-007-0003-z · Cited by 110
Rajendran, P. M., Dolev, J. C., Heaphy, M. R., et al. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.10.1227 · Cited by 72
M�nkem�ller, K. E., Lazenby, A. J., Lee, D. H., et al. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1587-z · Cited by 67
Demeter, L. M., Hughes, M. D., Coombs, R. W., Jackson, J. B., Grimes, J. M., Bosch, R. J., Fiscus, S. A., Spector, S. A., Squires, K., Fischl, M. A., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00007 · Cited by 65
Lepri, A. C., Miller, V., Phillips, A. N., et al. (2001) · AIDS · doi:10.1097/00002030-200101050-00008 · Cited by 55
Huruy, K., Mulu, A., Mengistu, G., et al. (2008) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2008.205 · Cited by 54
Brown, M. M., Cartledge, J. D., & Miller, R. F. (2006) · International Journal of STD & AIDS · doi:10.1258/095646206778145712 · Cited by 50
Kestens, L., Seddiki, N., & Bohjanen, P. R. (2008) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328302ebbb · Cited by 47
Sungkanuparph, S., Jongwutiwes, U., & Kiertiburanakul, S. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318061b5eb · Cited by 46
Delfos, N. M., Collen, A. F., & Kroon, F. P. (2004) · AIDS · doi:10.1097/00002030-200403050-00019 · Cited by 36
Sweet's syndrome following abacavir therapy
Giudice, P. D., Vandenbos, F., Perrin, C., et al. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.09.033 · Cited by 30
Park, W. B., Choe, P. G., Jo, J. H., et al. (2006) · AIDS · doi:10.1097/qad.0b013e328010f201 · Cited by 28
García, F., Alonso, M. A. M., Romeu, J., et al. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200009010-00004 · Cited by 25
An HIV-Positive Man with Generalized Rash
Mackowiak, P. A. (2004) · Clinical Infectious Diseases · doi:10.1086/426550 · Cited by 18
a, F. G., Alonso, M. A. M., Romeu, J., et al. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200009010-00004 · Cited by 14
Nacher, M., Vantilcke, V., Huber, F., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3282f02a3a · Cited by 7
Cited by
Maziarz, E. K., & Perfect, J. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.006 · Cited by 698
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
Haddow, L. J., Colebunders, R., Meintjes, G., Lawn, S. D., Elliott, J. H., Manabe, Y. C., Bohjanen, P. R., Sungkanuparph, S., Easterbrook, P. J., French, M. A., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70170-5 · Cited by 302
Self-citation
Metadata
- Authors
- Haddow, L. J., Easterbrook, P. J., Mosam, A., Khanyile, N. G., Parboosing, R., Moodley, P., & Moosa, M. S.
- Affiliations
- King's College London (GB)
- University of KwaZulu-Natal (ZA)
- Corresponding author
- Moosa, Mahomed‐Yunus S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 49
- Issue
- 9
- Pages
- 1424-1432
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2148645060
- Cited by
- 114
- References
- 39
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 11 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 10 · 2012: 9
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- immune reconstitution inflammatory syndrome, case definition, antiretroviral therapy initiation, kappa agreement, opportunistic infections, inflammatory skin diseases, joint diseases, tuberculosis, South Africa, HIV cohort, diagnostic criteria revision
- MeSH terms
- Adult, Female, Humans, Male, Prospective Studies, South Africa, Anti-HIV Agents, Immune Reconstitution Inflammatory Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.